ALKtALK

  • ALKtALK: Dr. Alex Drilon

    ALKtALK

    New Data, New Directions: Neladalkib (NVL-655) and Precision Oncology in ALK-positive Cancer Alexander Drilon, MD, is a thoracic oncologist and Chief of the Early Drug Development Service at Memorial Sloan Kettering Cancer […]